Trial site
Velocity Clinical Research, Salt Lake City
- 8running trials
- 18closed trials
The trials here
What the 26 trials at this site are about, from their registry records.
- Conditions
- Obesity4 trials
- Coeliac disease3 trials
- Diabetic neuropathy3 trials
- Gout3 trials
- Type 2 diabetes2 trials
- Asthma1 trial
- Chronic kidney disease1 trial
- Cushing's syndrome1 trial
- Fatty liver disease (MASLD/MASH)1 trial
- Gastroparesis1 trial
- Liver cirrhosis1 trial
- Lyme disease1 trial
- and 1 more
- Phase
- Phase 315 trials
- Phase 27 trials
- Phase 42 trials
- Early phase 11 trial
- Phase 1/21 trial
- Status
- Completed16 trials
- Active, not recruiting4 trials
- Recruiting3 trials
- Not yet recruiting1 trial
- Terminated1 trial
- Withdrawn1 trial
- Lead sponsor
- Eli Lilly and Company3 trials
- Amgen2 trials
- LG Chem2 trials
- Pfizer2 trials
- Vertex Pharmaceuticals Incorporated2 trials
- and 15 more
Running trials
Recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Recruiting
A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)
Recruiting
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Coeliac disease1 recruiting
- Cushing's syndrome1 recruiting
- Diabetic neuropathy1 recruiting
- Obesity1 recruiting
- Type 2 diabetes1 recruiting
Closed trials
Completed
Efficacy and Safety Trial of BHV-2100 for the Acute Treatment of Migraine
Completed
Study of CD388 for the Prevention of Influenza in Subjects Not at Risk for Influenza Complications
Completed
Recruiting
Completed
Completed
A Study of LY3556050 in Adult Participants With Diabetic Peripheral Neuropathic Pain
Completed
Completed
Tigulixostat, Phase 3 Study, Allopurinol Controlled in Gout Patients
Completed
Completed
Safety Study of a Vaccine to Help Protect Against Lyme Disease in Healthy Children
Terminated
Completed
Tigulixostat, Phase 3 Study, Placebo Controlled in Gout Patients
Completed
A Study of mRNA-1010 Seasonal Influenza Vaccine in Adults 50 Years Old and Older
Completed
A Study to Evaluate a Modified RNA Vaccine Against Influenza in Adults 18 Years of Age or Older
Completed
A Comparison of PT027 vs PT007 Used as Needed in Participants With Asthma
Completed
Completed
Completed
Site data: ClinicalTrials.govUpdated 18 Nov 2026